✦ LIBER ✦

Anticancer drugs: Unleashing p53

✍ Scribed by Kirkpatrick, Peter

Book ID: 109949429
Publisher: Nature Publishing Group
Year: 2004
Tongue: English
Weight: 96 KB
Volume: 3
Category: Article
ISSN: 1474-1776
DOI: 10.1038/nrd1313

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Unleashing p53

✍ Kirkpatrick, Peter 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 102 KB

Anticancer drugs: Stapled peptide rescue

Anticancer drugs: Stapled peptide rescues p53

✍ Crunkhorn, Sarah 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 184 KB

P53: An ubiquitous target of anticancer

P53: An ubiquitous target of anticancer drugs

✍ Mikhail V. Blagosklonny 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 113 KB

## Abstract The p53 tumor suppressor can induce growth arrest, apoptosis and cell senescence. Not surprisingly, p53 is an appealing target for therapeutic intervention. Although current anticancer agents do not directly interact with p53, these agents (including DNA damaging drugs, antimetabolites,

Anticancer drugs

✍ Reese, David M. 📂 Article 📅 1995 🏛 Nature Publishing Group 🌐 English ⚖ 440 KB

DNA damage, p53 and anticancer therapies

✍ Milner, Jo 📂 Article 📅 1995 🏛 Nature Publishing Group 🌐 English ⚖ 519 KB

P-glycoprotein and resistance to antican

P-glycoprotein and resistance to anticancer drugs

✍ Victor Ling 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 661 KB

Advances in chemotherapeutic treatment of human cancers will depend on our acquiring a real understanding of what factors limit successful therapy. One factor postulated to be important is the acquisition of a drug resistance phenotype by the patient's malignant cells. Particularly, it is thought th